NCT02160678View on ClinicalTrials.gov

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

1,741

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Acne Vulgaris
Interventions
DRUG

Vehicle

Cream Vehicle (placebo) (G \& W Laboratories, Inc.)- vehicle

DRUG

Tazarotene Cream, 0.1 %

Tazarotene Cream, 0.1 % (G \& W Laboratories, Inc.) - test product

DRUG

Tazorac Cream, 0.1%

Tazorac Cream, 0.1% (Allergan, Inc.) - reference product

Trial Locations (1)

60005

Altman Dermatology Associates, Arlington Hts.

Sponsors
All Listed Sponsors
lead

G & W Laboratories Inc.

INDUSTRY

NCT02160678 - Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter